Integra LifeSciences Holdings Corp <IART.O>: UBS Initiates Coverage With Neutral Rating; Target Price $19
IART•Related News
HF Sinclair posts highest profit since 2022, plans lubricants separation
DINO•
Kiniksa Q2 FY26 net income rises 42.7% to $25.4 million; revenue climbs 55.4% to $243.6 million
KNSA•
Most brokerages see Fed on hold, but hawkish view grows
SPY•
Boeing misses Q2 core loss per share estimates as VC-25B charges weigh
BA•
Boeing FY26 Q2 GAAP loss per share narrows to ($0.67); revenue rises 8% to $24.6 billion
BA•